Clinical Trials List
Protocol NumberPCI32765CLL3002
2014-03-19 - 2016-12-31
Phase III
Terminated3
-
Trial Applicant
Johnson & Johnson
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- 徐思淳 Division of Hematology & Oncology
- HSIN-AN HOU Division of Hematology & Oncology
- - - Division of Hematology & Oncology
- Wen-Chien Chou Division of Hematology & Oncology
- 林建廷 Division of Hematology & Oncology
- 陳尹愷 Division of Hematology & Oncology
- MING YAO Division of Hematology & Oncology
- 李啟誠 Division of Hematology & Oncology
- 蔡偉 Division of Hematology & Oncology
- - - Division of Hematology & Oncology
- Sheng-chieh Chou Division of Hematology & Oncology
- Jih-Luh Tang Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Wei-Pang Chung Division of Hematology & Oncology
- Yu-Min Yeh Division of Hematology & Oncology
- Shang-Yin Wu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
150 participants
